Literature DB >> 436984

Characteristics of transcriptionally active and inactive neuronal and nonastrocytic glial rat brain chromatin fractions.

H I Sarkander, H J Dulce.   

Abstract

Rapid and reliable fractionation of neuronal and nonastrocytic glial (NAG) cerebral rat brain chromatin in transcribable and repressed portions was achieved employing the DNAase II/Mg++-solubility method of Gottesfeld et al. (1974). Compositional and transcriptional properties of these fractions have been investigated. Compared to transcriptionally repressed fractions, template-active neuronal and NAG chromatin fractions are associated with an increased content of nonhistone chromosomal (NHC-) proteins. Both of the transcribable as well as both of the repressed fractions are strikingly different in their composition as assessed by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis. Comparative acid urea gel electrophoretic patterns of histones revealed that histone fraction H 1 is almost completely absent in actively transcribed neuronal chromatin and reduced in the corresponding NAG fraction while in template-inactive neuronal and NAG chromatin all five main histone fractions are present in equal amounts. The total number of RNA initiation sites available for exogenously added homologous RNA polymerase on template-active and -inactive neuronal and NAG chromatin was quantitatively measured under assay conditions completely eliminating reinitiation. Unlike the template-active neuronal and NAG fractions which are differently enriched in RNA initiation sites, transcriptionally more repressed neuronal and NAG fractions demonstrated a minimal ability to initiate RNA synthesis. Under assay conditions allowing repeated initiation of RNA chains at the same initiation site, rat brain RNA polymerase molecules were found to utilize neuronal initiation sites more frequently than NAG ones.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 436984     DOI: 10.1007/bf00236788

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  55 in total

1.  Electron microscopic and biochemical evidence that chromatin structure is a repeating unit.

Authors:  P Oudet; M Gross-Bellard; P Chambon
Journal:  Cell       Date:  1975-04       Impact factor: 41.582

2.  A comparison of the digestion of nuclei and chromatin by staphylococcal nuclease.

Authors:  B Sollner-Webb; G Felsenfeld
Journal:  Biochemistry       Date:  1975-07       Impact factor: 3.162

3.  Electron microscopy of defined lengths of chromatin.

Authors:  J T Finch; M Noll; R D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

4.  Heterogeneity of chromatin subunits in vitro and location of histone H1.

Authors:  A J Varshavsky; V V Bakayev; G P Georgiev
Journal:  Nucleic Acids Res       Date:  1976-02       Impact factor: 16.971

5.  Removal of histone H1 exposes a fifty base pair DNA segment between nucleosomes.

Authors:  J P Whitlock; R T Simpson
Journal:  Biochemistry       Date:  1976-07-27       Impact factor: 3.162

6.  Comparative subunit structure of HeLa, yeast, and chicken erythrocyte chromatin.

Authors:  D Lohr; J Corden; K Tatchell; R T Kovacic; K E Van Holde
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Transcription of repeated and unique DNA sequences in brain nuclei.

Authors:  K Soga; Y Takahashi
Journal:  J Neurochem       Date:  1976-01       Impact factor: 5.372

9.  Higher order coiling of DNA in chromatin.

Authors:  A Worcel; C Benyajati
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

10.  Repression of glial RNA transcription during the development of 6-aminonic-otinamide (6-AN)-induced acute gliopathy.

Authors:  H I Sarkander; E Knoll-Köhler; J Cervos-Navarro
Journal:  J Pharmacol Exp Ther       Date:  1978-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.